Mosaicbio
Boulder, US · Delaware corporation · 1 known investors
Mosaic Biosciences is an integrated biologics discovery partner offering antibody discovery, protein engineering, and translational pharmacology services to advance complex antibody and protein therapeutics from concept to candidate selection. The company serves biopharmaceutical organizations developing biologics.
BiotechDeep Tech
Founders & leadership
EF
Eric FurfineChief Scientific Officer
AK
Alexei KazantsevVice President Protein Design and Engineering
TM
Tracey MullenChief Strategy Officer
SG
Scott GlaserSVP, Biologics Discovery
DM
Dan MitchellDirector
MS
Martin StantonExecutive Officer, Director
RC
Rob CaponeDirector
JW
Jeanette WelshDirector
Investors · 1
Reported raises · per SEC filings
Form D private placements▶$11.4MraisedJan 2023 · 4 investors · BiotechnologyRule 506(b)
▶$11.4MraisedJan 2023 · 4 investors · Biotechnology
Rule 506(b)Officers, directors & promoters on the filing
- Rob CaponeDirector
- Jeanette WelshDirector
- Dan MitchellDirector
- Martin StantonExecutive Officer, Director
- Eric FurfineDirector
- Offering amount
- $11.4M
- Amount sold
- $11.4M
- First sale
- Apr 2022
- Incorporated
- Corporation, Delaware
- Federal exemptions
- 06b
Source: SEC EDGAR Form D. Amounts as filed; amended filings shown once at their latest values.